JPMORGAN CHASE & CO - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 8 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$80,223,396
+8881.0%
661,800
+8384.6%
0.01%
Q2 2023$893,256
-98.3%
7,800
-97.9%
0.00%
-100.0%
Q1 2023$51,562,000
+142830.0%
374,100
+34.4%
0.01%
+20.0%
Q4 2022$36,075
-99.4%
278,400
+378.4%
0.01%
+400.0%
Q3 2022$6,433,000
+64.4%
58,200
+16.2%
0.00%
Q1 2022$3,914,000
-89.3%
50,100
-87.6%
0.00%
-100.0%
Q4 2021$36,416,000
+96.9%
404,400
+102.2%
0.00%
+100.0%
Q3 2021$18,496,000
+261.6%
200,000
+566.7%
0.00%
+100.0%
Q4 2020$5,115,000
+189.6%
30,000
+140.0%
0.00%
Q3 2020$1,766,000
-90.5%
12,500
-91.3%
0.00%
-100.0%
Q4 2019$18,595,000
+230.5%
144,100
+92.9%
0.00%
+200.0%
Q3 2019$5,626,000
-88.3%
74,700
-79.8%
0.00%
-88.9%
Q2 2019$48,063,000
+84.4%
370,400
+69.4%
0.01%
+80.0%
Q1 2019$26,067,000
+784.5%
218,700
+710.0%
0.01%
+400.0%
Q4 2018$2,947,000
-58.5%
27,000
-38.6%
0.00%0.0%
Q3 2018$7,106,000
+19.5%
44,000
-2.2%
0.00%0.0%
Q2 2018$5,948,000
+25.8%
45,000
-47.1%
0.00%0.0%
Q4 2017$4,729,000
+46.4%
85,000
+24.1%
0.00%0.0%
Q3 2017$3,230,000
+488.3%
68,500
+242.5%
0.00%
Q4 2016$549,00020,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 200,000$14,992,0000.87%
GROUP ONE TRADING, L.P. 276,500$20,726,0000.03%
SG Americas Securities, LLC 75,000$398,0000.00%
JANE STREET GROUP, LLC 101,000$7,571,0000.00%
SIMPLEX TRADING, LLC 25,700$1,926,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders